CDH17 and neoplasm: Overall, these findings suggest that the nanobodies Nb289 and Nb535, identified through deep sequencing, hold potential for use in tumor models expressing both human and murine CDH17 antigens, thereby extending the applications of CDH17 nanobodies to a certain extent.